Viral Hepatitis B and Its Implications for Public Health in DR Congo: A Systematic Review
Marcellin Mengouo Nimpa,
Hermès Karemere,
Christian Ngandu,
Franck-Fortune Mboussou,
M. Carolina Danovaro-Holliday,
Dalau Nkamba,
André Bita Fouda,
Bienvenu Nguejio,
Sifa Kakozi,
Aimé Mwana-Wabene Cikomola,
Jean-Crispin Mukendi,
Dieudonné Mwamba,
Moise Désiré Yapi,
Richard Bahizire Riziki,
Cedric Mwanga,
John Otomba,
Jean Baptiste Nikiema,
Boureima Hama Sambo,
Daniel Katuashi Ishoso
Affiliations
Marcellin Mengouo Nimpa
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Hermès Karemere
École Régionale de Santé Publique, Université Catholique de Bukavu, Bukavu 11103, Democratic Republic of the Congo
Christian Ngandu
National Institute of Public Health, Kinshasa 01206, Democratic Republic of the Congo
Franck-Fortune Mboussou
World Health Organization African Regional Office, Brazzaville P.O. Box 06, Congo
M. Carolina Danovaro-Holliday
Immunization, Analytics and Insights (IAI), Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), 1211 Geneva, Switzerland
Dalau Nkamba
Kinshasa School of Public Health, University of Kinshasa, Kinshasa 01206, Democratic Republic of the Congo
André Bita Fouda
World Health Organization African Regional Office, Brazzaville P.O. Box 06, Congo
Bienvenu Nguejio
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Sifa Kakozi
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Aimé Mwana-Wabene Cikomola
Expanded Program of Immunization, Kinshasa 01206, Democratic Republic of the Congo
Jean-Crispin Mukendi
Expanded Program of Immunization, Kinshasa 01206, Democratic Republic of the Congo
Dieudonné Mwamba
National Institute of Public Health, Kinshasa 01206, Democratic Republic of the Congo
Moise Désiré Yapi
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Richard Bahizire Riziki
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Cedric Mwanga
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
John Otomba
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Jean Baptiste Nikiema
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Boureima Hama Sambo
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Daniel Katuashi Ishoso
World Health Organization (WHO) Country Office, Kinshasa 01206, Democratic Republic of the Congo
Background: The prevalence of hepatitis B virus infection remains high in the Democratic Republic of Congo (DRC), constituting a public health problem in view of the fatal complications it causes, notably cirrhosis and hepatocellular carcinoma. The aim of this study was to provide an overview of the situation of viral hepatitis B in the DRC and in particular its implications for public health. Methods: A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) group guidelines. Google Scholar, PubMed, and ResearchGate were used as databases. The review essentially analyzed the viral hepatitis B (HBV) vaccination status of study subjects, diagnostic means, HBV genotypes in DR Congo, seroprevalence of HBV infection, subjects’ level of knowledge and perceptions of HBV, co-infection/comorbidity with HBV infection, factors associated with HBV infection and public health issues raised by HBV infection. Results: The vast majority of studies (69%) were carried out to determine the seroprevalence of HBV infection. The Determine rapid test was the most widely used test (10 studies), sometimes combined with ELISA (3 studies) and polymerase chain reaction (PCR) (1 study, for genotyping). Some of the public health issues raised by hepatitis B virus infection were identified in the course of the included studies, in relation to co-infection, comorbidity, associated factors, and individuals’ level of knowledge and perceptions of HBV. Certain factors were identified as being closely associated with HBV, notably healthcare professions (e.g., doctor, laboratory technician) and having several sexual partners. In terms of perception of HBV, the hepatitis B virus is recognized as dangerous, and the majority of people questioned in the various studies were aware that vaccination remains the most effective means of prevention. Conclusions: Hepatitis B is a highly contagious infectious disease present in the DRC, with a higher prevalence among healthcare professionals, sex workers, patients with certain diseases including HIV, and people with a history of blood transfusion. The surveillance system within the national blood transfusion program needs to be strengthened. Raising public awareness of the seriousness of viral hepatitis B, offering vaccination to at-risk populations, and systematically screening pregnant women and blood donors for HBV infection could help reduce the prevalence of viral hepatitis B.